Contrast-enhanced ultrasound and magnetic resonance imaging for the evaluation of neovascularisation in carotid artery plaques

Contrast-enhanced ultrasound and magnetic resonance imaging for the evaluation of neovascularisation in carotid artery plaques - CE-US and MRI: evaluating plaque neovascularisation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31966

Enrollment

Registered

2008-03-17

Start date

2009-03-16

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriosclerosis Atherosclerosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Subjects with a >70% carotid artery stenosis who are scheduled for carotid endarterectomy. -Age 18 years or older

Exclusion criteria

Exclusion criteria: -Patients with acute coronary syndrome or clinically unstable ischaemic cardiac disease. -Patients with right-to-left shunts, severe pulmonary hypertension, uncontrolled systemic hypertension, and adult respiratory distress syndrome. -Pregnant and lactating women -Patients with documented allergy to contrast media or a renal clearance

Design outcomes

Primary

Measure	Time frame
The accuracy of contrast-enhanced ultrasound and MRI in depicting neovascluarisation in a carotid artery plaque.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results